20 October 2008
WALCOM GROUP LIMITED
("Walcom" or "the Company")
Further re: Acquisition of Beijing New World Bio-technology Company Limited
("BNWB")
Further to the announcement of 30 June 2008, detailing the acquisition of the
entire issued share capital of BNWB, Walcom announces that the outstanding
conditions have now been satisfied. Accordingly, the 3,923,497 ordinary shares
to be issued in consideration for the acquisition have now been allotted and
application has been made for the new ordinary shares to be admitted to trading
on AIM. Trading in the new ordinary shares is expected to commence on 23
October 2008. Following admission of the new shares, the Company will have
68,834,388 ordinary shares admitted to trading on AIM.
Enquiries:
Walcom
Francis Chi (Chief Executive Officer) Tel: +852 2494 0133
Albert Wong (Chief Financial Officer)
John East & Partners Limited
Jeffrey Coburn / Bidhi Bhoma Tel: +44 20 7628 2200
About Walcom:
Walcom is a Hong Kong based manufacturer and distributor of `clean' animal feed
additives. Walcom's products are based on Cysteamine, a natural metabolite
generated in animals' bodies which participates in animals' physiological
`growth axis' to stimulate the animals' natural growth hormone level. The
Company's feed additives improve the health of the animals, reduce mortality
rates, shorten the time taken to reduce maturity, increase the protein content
in animal food products, increase egg laying and reduce eggshell breakage and
build resistance to disease. Walcom's feed additives are `non hormonal', `non
antibiotic' and `non gene-altering'.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.